
Oregon AG Files Lawsuit to Block Covetrus MWI Veterinary Merger
Summary
- Oregon Attorney General Dan Rayfield is suing to block a $3.5 billion merger between Covetrus and MWI Veterinary Supply.
- The lawsuit alleges the merger would eliminate competition, potentially raising prices for veterinary clinics and pet owners.
- Covetrus and MWI are the largest distributors of veterinary products, currently engaged in a 'price war' that benefits clinics.
- The Federal Trade Commission and 12 other states have joined Oregon in challenging the deal under federal antitrust law.
- The legal action seeks a permanent injunction to prevent the acquisition from being finalized.
Oregon AG Challenges Veterinary Supply Merger
The lawsuit contends that the proposed acquisition would eliminate crucial competition, leading to higher costs for veterinary clinics and, ultimately, for pet owners across Oregon.
Oregon Attorney General Dan Rayfield has initiated legal action to prevent a proposed $3.5 billion merger between Covetrus and MWI Veterinary Supply. This lawsuit, part of a broader federal challenge, aims to block the acquisition of MWI Veterinary Supply by Covetrus, citing concerns that the consolidation could lead to increased costs for veterinary clinics and, subsequently, for pet owners throughout Oregon.
Covetrus and MWI Veterinary Supply stand as the two largest distributors of essential products used by veterinary clinics nationwide. Their extensive inventory includes a wide array of items, from critical medicines and vaccines to surgical instruments and everyday necessities like gloves, gauze, and syringes. These companies serve a diverse client base, ranging from small, single-veterinarian practices in rural areas to large corporate chains with hundreds of locations across the country.
Antitrust Concerns and Market Dynamics
The core of the challenge against the Covetrus MWI veterinary supply merger lies in its potential to severely diminish competition within the market for veterinary supplies. According to the complaint, filed jointly by the Federal Trade Commission (FTC), Oregon, and a bipartisan coalition of twelve other states, the two companies have historically engaged in intense competition, often described as a 'price war.' This dynamic has seen MWI reduce prices, prompting Covetrus to respond with its own competitive pricing and rebate offers.
This robust competition has been further amplified in recent years by the advent of online platforms, which empower veterinary clinics to readily compare prices between the two dominant distributors. This transparency allows clinics to leverage one company's pricing against the other to secure more favorable deals. The lawsuit contends that the proposed acquisition would eliminate crucial competition, leading to higher costs for veterinary clinics and, ultimately, for pet owners across Oregon. The legal challenge also names the private equity firms Clayton, Dubilier & Rice and TPG as owners of Covetrus.
Legal Basis and Broader Implications
The legal filing asserts that the proposed merger would result in such a highly concentrated market that it should be presumed illegal under federal antitrust law. Oregon is one of thirteen states participating in this significant FTC Oregon merger challenge, alongside Arizona, Arkansas, California, Colorado, Maine, Michigan, Minnesota, Nebraska, New York, North Carolina, Ohio, and Texas. The collective action seeks a permanent injunction from the court to prevent the deal from proceeding.
Attorney General Dan Rayfield emphasized the importance of accessible and affordable pet care, stating that Oregonians should not face financial barriers to treating their sick pets. He highlighted that the existing competition between Covetrus and MWI currently helps keep prices in check, and the elimination of one competitor would inevitably shift the burden of increased costs onto clinics and pet owners. The outcome of this Clayton Dubilier Rice TPG lawsuit could establish important precedents for future merger challenges, particularly in concentrated industries.
Practical Implications
Lawyers advising M&A deals, particularly in concentrated markets or involving private equity, should note the heightened antitrust scrutiny from state attorneys general and the FTC, as this case could set precedents for merger challenges based on potential price increases for end-users. Compliance officers should assess their companies' exposure to similar antitrust challenges if contemplating acquisitions in concentrated sectors.
Source
How does this affect you?
Get an AI analysis of this article grounded in your jurisdictions, practice areas, and any policy documents you've uploaded to Wansom.
Finish Reading the Full Story and the Expert Analysis.
Get the latest legal & regulatory intelligence in United States
Wansom is AI and can make mistakes.
